Find policies, billing codes, payers, states, and providers
CPT 81376: HLA Class II Typing, Low/Intermediate-Resolution Technical
CPT code 81376 covers the technical laboratory component for low- or intermediate-resolution molecular assessment of human leukocyte antigen (HLA) genes at one Class II locus. This code is used for laboratory processing and analysis when HLA Class II typing is required for transplant compatibility, immunogenetics evaluations, or other clinical indications where class II allele group identification is sufficient.
Nationally, HLA testing supports transplant matching, donor selection, and certain disease risk assessments, making accurate coding and reimbursement important for labs and providers. Key payers in the national landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. When present in a claim, CPT code 81376 identifies the technical component of molecular HLA Class II testing performed at clinical or hospital laboratories.
Readers will find benchmarks and context on service utilization and coding practice, relevant clinical context about HLA Class II testing, and notes on payer coverage patterns and policy considerations where available. Data not available in the input will be identified as such.
Customize your policy alerts
Sign up for cpt 81376 policy alerts
Get alerted when payer policies referencing 81376 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 81376 describes a technical laboratory test that performs low- or intermediate-resolution molecular assessment of human leukocyte antigen (HLA) genes for a single Class II locus. The service involves laboratory processing and analysis using molecular techniques to determine HLA Class II typing at a resolution level used for clinical matching and immune compatibility assessment.
Service Type: Laboratory — Molecular HLA Class II typing (technical component)
Typical Site of Service: Clinical laboratory or hospital laboratory